netFormulary The Pennine Acute Hospitals NHS
NHS Trust Formulary  
 Search
 Formulary Chapter 5: Infections - Full Section
Notes:
This chapter of the formulary is not an antibiotic prescribing guide and is not intended to guide treatment choice.

Please refer to the relevant Pennine Acute policies (e.g. the Antibiotic Policy for Adult Patients, or Antibiotic Guidelines for Paediatrics) when making treatment choices.
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
05.01 Antibacterial drugs (0,0)
05.01.01 Penicillins (0,0)
05.01.01.01 Benzylpenicillin and phenoxymethylpenicillin (2,0)
05.01.01.02 Penicillinase-resistant penicillins (2,0)
05.01.01.03 Broad-spectrum penicillins (2,2)
05.01.01.04 Antipseudomonal penicillins (2,0)
05.01.01.05 Mecillinams (1,0)
05.01.02 Cephalosporins, carbapenems and other beta-lactams (0,0)
05.01.02.01 Cephalosporins (6,5)
05.01.02.02 Carbapenems (2,2)
05.01.02.03 Other beta-lactam antibiotics (1,1)
05.01.03 Tetracyclines (4,2)
Tigecycline (1,0)
05.01.04 Aminoglycosides (4,1)
05.01.05 Macrolides (3,1)
05.01.06 Clindamycin (1,0)
05.01.07 Some other antibacterials (0,0)
Chloramphenicol (1,0)
Fosfomycin (0,0)
Fusidic acid (1,0)
Vancomycin and teicoplanin (2,0)
Daptomycin (1,0)
Linezolid (1,0)
Polymyxins (1,2)
Rifaximin (1,0)
Fidaxomicin (1,0)
05.01.08 Sulphonamides and trimethoprim (3,0)
05.01.09 Antituberculosis drugs (17,1)
05.01.10 Antileprotic drugs (3,0)
05.01.11 Metronidazole and tinidazole (2,0)
05.01.12 Quinolones (4,3)
05.01.13 Urinary-tract infections (3,1)
05.02 Antifungal drugs (0,2)
05.02.01 Triazole antifungals (4,0)
05.02.02 Imidazole antifungals (0,0)
05.02.03 Polyene antifungals (1,2)
05.02.04 Echinocandin antifungals (1,2)
05.02.05 Other antifungals (2,1)
05.03 Antiviral drugs (0,0)
05.03.01 HIV infection (0,0)
Nucleoside reverse transcriptase inhibitors (17,0)
Protease inhibitors (8,4)
Non-nucleoside reverse transcriptase inhibitors (4,0)
Other antiretrovirals (5,0)
Pharmacokinetic enhancers of antiretrovirals (1,0)
05.03.02 Herpesvirus infections (0,1)
05.03.02.01 Herpes simplex and varicella-zoster infection (2,3)
05.03.02.02 Cytomegalovirus infection (4,0)
05.03.03 Viral hepatitis (0,0)
05.03.03.01 Chronic hepatitis B (5,0)
05.03.03.02 Chronic hepatitis C (11,4)
05.03.04 Influenza (2,1)
05.03.05 Respiratory syncytial virus (1,0)
05.04 Antiprotozoal drugs (0,0)
05.04.01 Antimalarials (0,0)
Treatment of malaria (10,0)
Prophylaxis against malaria (0,0)
05.04.02 Amoebicides (3,0)
05.04.03 Trichomonacides (0,0)
05.04.04 Antigiardial drugs (0,1)
05.04.05 Leishmaniacides (2,0)
05.04.06 Trypanocides (0,0)
05.04.07 Drugs for toxoplasmosis (4,0)
05.04.08 Drugs for pneumocystis pneumonia (5,0)
05.05 Anthelmintics (0,0)
05.05.01 Drugs for threadworms (2,1)
05.05.02 Ascaricides (1,0)
05.05.03 Drugs for tapeworm infections (3,0)
05.05.04 Drugs for hookworms (2,0)
05.05.05 Schistosomicides (1,0)
05.05.06 Filaricides (2,0)
05.05.07 Drugs for cutaneous larva migrans (3,0)
05.05.08 Drugs for strongyloidiasis (2,0)
netFormulary